HL7 FHIR: A Standard You Can Use Today!
A Recap of the HL7 FHIR Applications Roundtable
“A standard is not used because we created it. It is a standard because people use it.”
This familiar quote from Charles Jaffe, MD, PhD, CEO of HL7, could have been the motto for the inaugural FHIR Applications Roundtable held this July at Harvard Medical School in Boston.
As so many of the smiling attendees attested, this was indeed a very different kind of meeting.
The premise was to show how widespread HL7 Fast Healthcare Interoperability Resources (FHIR®) usage already is, and the answer was – more than we could have ever imagined.
The FHIR is spreading
Although FHIR is currently designated as a Standard for Trial Use (STU), it has already captivated the development community who is drawn to its advanced, elegant technology platform. The roundtable, like most FHIR events, cements the impression that interoperability through FHIR is not a pipe dream, but a burgeoning reality.